Home » Business, Europe, Health & Medicine, Lifestyle, Pharmaceuticals & Biotech » Global respiratory drugs and devices market expected to grow at a CAGR of 7.8% during 2016-2021
“Homecare market to drive the respiratory drugs and devices market.”

Indore, November 2016:  Orion Market Research (OMR), recently published a market research report on Global Respiratory Drugs and Devices Market. According to the OMR analysis the global respiratory drugs and devices market expected to grow at a CAGR of 7.8% during 2016-2021. The report provides a detailed overview, market determinants, company profiling, sector analysis, market segmentation, geographical analysis, strategic recommendations, market estimations, market insights and predictive analysis of the market.

The full report is available at Global Respiratory Drugs and Devices Market.

Every year around 6 million people lose their life due to respiratory diseases such as Asthma, COPD and others. Asthma and COPD are the most common occurring respiratory diseases. Drugs and devices market for the treatment of asthma and COPD alone account for 60% revenue. Changing lifestyles, growing aging population, high level of pollution are some of the major contributors to the high prevalence of respiratory diseases. Most of the manufacturers are involved in research and development to develop drugs which would have long-term effect compared to currently available medicines. This could help in reducing the cost of treatment since the overall doses will be reduced. Manufacturers are also focused on developing portable and home care devices. The market for portable and homecare devices will be the fastest growing for the period of 2016-2021.

Global respiratory drugs and devices market is segmented on the basis of the region which includes North America, Europe, APAC and RoW. North America has the highest market share. The market is expected to grow at a stable CAGR. North American marker is followed by Europe, Asia-Pacific and Rest of the world. Asia Pacific market is expected to have highest CAGR amongst all regions for the forecasted period of 2016-2021. Some of the top companies profiled in the report include Philips Healthcare, Novartis, GSK, Covidien, Roche, Baxter International and others.

For related reports please visit http://www.omrglobal.com/reports-category/medical-devices/

The report covers:

• Comprehensive research methodology of respiratory drugs and devices market.

• In-depth analysis of macro and micro factors influencing the market guided by key recommendations.

• Analysis of regional regulations and other government policies impacting the global respiratory drugs and devices market.

• Insights about market determinants which are stimulating the global respiratory drugs and devices market.

• Detailed and extensive market segments with regional distribution of forecasted revenues

• Extensive profiles and recent developments of market players

 

About Orion Market Research

Orion Market Research (OMR) is an Indian research company known for its crisp and concise reports. The company is equipped with an experienced team and young brigade of analysts. The company provides quality syndicated research reports, customized research reports, Company profiling, consulting and other research-based services. OMR provide global and regional market reports of various domains such as healthcare, energy, IT, chemicals, and automobiles. OMR provide a 360-degree view of the market with parametric analysis, key market insights, key findings, statistical forecasts, competitive landscape, extensive segmentation, key trends, strategic recommendations and detailed company profiles.

Media Contact
Company Name: Orion Market Research
Contact Person: Anurag Tiwari
Email: tiwari@omrglobal.com
Phone: +917803040404
Address:202, Labbaik Regency, Palasia
City: Indore
State: Madhya Pradesh
Country: India
Website: www.omrglobal.com

Comments are closed.